Serial #99467602
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #99467602 Trademark

Serial Number: 99467602 • Registration: 8272964

Serial #99467602 is a trademark filed by SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. on October 28, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (10 trademarks)

37F, Main Tower, Lvjing Plaza,
Futian Dist. Shenzhen 518040 , CN

Entity Type: 99

Trademark Details

Filing Date

October 28, 2025

Registration Date

May 26, 2026

Published for Opposition

April 7, 2026

Goods & Services

Pharmaceutical preparations, namely, elixirs for the treatment of cardiovascular and cerebrovascular system, hematologic disorders, dermatological diseases, ophthalmic diseases, and gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and hypersensitivity diseases; Pharmaceutical preparations for the prevention of cardiovascular and cerebrovascular diseases, hematologic disorders, dermatological diseases, ophthalmic diseases, gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, respiratory system diseases, digestive system diseases, endocrine system diseases, immune system diseases, musculo-skeletal system diseases, and hypersensitivity diseases; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cardiovascular and cerebrovascular system, hematologic disorders, dermatological diseases, ophthalmic diseases, and gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and hypersensitivity diseases; Medicines made of Chinese traditional medicinal herbs; Vaccines for human use; Insulin; Dietetic foods adapted for medical use; Veterinary pharmaceutical preparations for the treatment of cardiovascular and cerebrovascular diseases, hematologic disorders, dermatological diseases, ophthalmic diseases, gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, respiratory system diseases, digestive system diseases, endocrine system diseases, immune system diseases, musculo-skeletal system diseases, and hypersensitivity diseases; Animal feed additive for use as a nutritional supplement for medical purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 26, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2026 CNSA
ASSIGNED TO EXAMINER
Mar 12, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 9, 2026 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 9, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 28, 2025 MAFR
NEW APPLICATION ENTERED
Oct 28, 2025 NWAP